期刊文献+

不同剂量丙种球蛋白治疗重症手足口病患儿的疗效分析 被引量:8

Analysis of different dose of gamma globulin in treatment of severe HFMD effect
在线阅读 下载PDF
导出
摘要 目的探讨不同剂量的丙种球蛋白治疗重症手足口病患儿的疗效。方法选取2009年3月~2013年3月来院就诊的重症手足口病患儿97例,分为3组。在基础治疗的基础上,A组给予IVIG0.2g/(kg·d)治疗;B组予IVIG1g/(kg·d)治疗。C组予羚羊角粉治疗。结果 A、B两组患者NSS好转、发热缓解、临床治愈时间比较,差异均无统计学意义(P>0.05)。A、B两组与C组比较,NSS好转、发热缓解、临床治愈时间比较,差异均有统计学意义(P<0.05)。A、B两组治疗10d后复查脑脊液及心电图正常和异常率比较,差异均无统计学意义(P>0.05)。结论及早使用IVIG对手足口病患儿疗效显著;使用大、小剂量IVIG治疗重症手足口病疗效相近。 Objective To study the curative effect of children with different dose of gamma globulin in the treatment of severe hand-foot-mouth disease. Methods 97 cases in the hospital with severe hand foot and mouth disease in,from 2009 March to 2013 March were divided into 3 groups.On the basis of conventional treatment, A group was given IVIG 0.2g/(kg .d) treatment;group B was treated with IVIG lg/(kg .d) treatment.C group was treated with antelope horn powder. Results NSS improving, fever,alleviate clinical cure time comparison between A and Bgroup,the difference was not statistically significant(P 〉 0.05).But NSS improved,fever,alleviate clinical cure time comparison among A,B two group and C group,the differences were statistically significant(P 〈 0.05).A, B two groups after 10 d treatment cerebrospinal fluid and normal ECG and abnormal rate, the difference is not statistically significant(P 〉 0.05). Conclusion Early use of IVIG significantly in children with hand-foot-and-mouth disease curative has effect;The use of large, small doses of IVIG had similar effect in treatment of severe hand-foot-mouth disease.
出处 《中国医药科学》 2013年第13期71-72,共2页 China Medicine And Pharmacy
关键词 丙种球蛋白 重症手足口病 疗效 Gamma globulin Hand-foot-and-mouth disease Curative effect
  • 相关文献

参考文献6

二级参考文献49

共引文献254

同被引文献94

  • 1何时军,陈贤楠.病毒相关性小儿危重病[J].中国小儿急救医学,2006,13(1):72-74. 被引量:37
  • 2蔡栩栩,刘春峰,邢艳玲,王华.重症手足口病(附三例报告)[J].中国小儿急救医学,2006,13(6):556-558. 被引量:110
  • 3蒋心华,潘孝彰,王岱明.现代感染病学[M].上海:上海医科大学出版社,1998:642-656.
  • 4Huang CC. Neurologic conplications in children with en- terovirus 71 infection [J]. New Engl J Med, ~999,341 (3) : 936-942.
  • 5Nolan MA,Craig ME, Lahra MM,et al. Survival after pul- monary edema due to enterovirus 71 encephalitis [J]. Neu- rology, 2003,60 (10) : 1651-1656.
  • 6Kiener TK, Jia Q, Meng T, et al. A novel universal neutralizing mono-clonal antibody against enterovirus 71 that targets the highly conservedknob region of VP3 protein [ J ]. PLoS Negl Trop Dis, 2014,8(5):e2895.
  • 7Zhu F,Xu W,Xia J,et al. Efficacy,safety,and immunogenicity of an en-terovirus 71 vaccine in China[ J]. N Engl J Med, 2014 ,370(9) :818 -828.
  • 8Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of aninactivated alum-adjuvant enterovirus 71 vaccine in children in China: amulticentre, randomised, double-blind,placebo-controlled,phase 3 trial[J]. Lancet,2013 ,381(9882) :2024 -2032.
  • 9Cao R,Han J,Deng Y,et al. Presence of high-titer neutralizing antibodiesagainst enterovirus 71 in intravenous immunoglobulin manufactured fromChinese donors[ J]. Clin Infect Dis,2010,50( 1 ) :125 - 126.
  • 10McMinn P, Stratov I, Nagarajan L, et al. Neurological manifestations ofenterovirus 71 infection in children during an outbreak of hand,foot,andmouthdisease in Western Australia[ J]. Clin Infect Dis,2001,32 ( 2 ):236 -242.

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部